Ovarian Cancer TRACKFORWARD Project extension

Overview

The purpose of this grant opportunity is to support the extension of the Ovarian Cancer TRACKFORWARD Project that commenced in 2022 and aims to help investigators at the Peter MacCallum Cancer Centre monitor the emergence of BRCA reversions in ovarian cancer patients identified to carry a BRCA1 or BRCA2 mutation to understand their impact on subsequent treatment. This grant will provide funding to allow an extension of the project for an additional 18 months. To view the grant opportunity documents, please select the red "Grant Opportunity Documents" button on the left-hand side.